Rhamnolipids Global Market Report 2026

Rhamnolipids are a type of biosurfactant produced by certain bacteria, notably Pseudomonas aeruginosa, characterized by a rhamnose sugar head group linked to one or two fatty acid chains. These compounds find diverse applications, serving as emulsifiers, detergents, and aiding in environmental remediation by reducing surface tension and enhancing the solubility of hydrophobic compounds.

The primary types of rhamnolipids include mono-rhamnolipids and di-rhamnolipids. Mono-rhamnolipids consist of a single rhamnose sugar molecule attached to one fatty acid chain. Various product variations such as rhamnolipids R1, R2, R3, and R4 cater to different applications spanning surfactants, cosmetics, agriculture, food, pharmaceuticals, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the rhamnolipids market by increasing costs for fermentation equipment, downstream purification systems, and specialty nutrients used in microbial production. These effects are most visible in North America and Europe where biosurfactant innovation is concentrated. Higher tariffs have impacted production economics and commercialization timelines. To address this, companies are investing in localized fermentation capacity, optimizing microbial yields, and securing regional supply chains. In some cases, tariffs have strengthened domestic biotech manufacturing ecosystems.

The rhamnolipids market research report is one of a series of new reports from The Business Research Company that provides rhamnolipids market statistics, including rhamnolipids industry global market size, regional shares, competitors with a rhamnolipids market share, detailed rhamnolipids market segments, market trends and opportunities, and any further data you may need to thrive in the rhamnolipids industry. This rhamnolipids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rhamnolipids market size has grown strongly in recent years. It will grow from $2.87 billion in 2025 to $3.14 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to research in microbial surfactants, demand for eco friendly detergents, use in oil spill remediation, biotechnology advancements, growth of bio-based chemicals.

The rhamnolipids market size is expected to see strong growth in the next few years. It will grow to $4.37 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to stricter environmental regulations, expansion of sustainable agriculture, growth of green cosmetics, advances in fermentation technology, rising demand for biodegradable ingredients. Major trends in the forecast period include rising adoption of biosurfactants, growing use in green cleaning products, expansion of agricultural applications, increasing demand for biodegradable surfactants, focus on microbial fermentation scaling.

Increasing demand for personal care products is expected to drive the growth of the rhamnolipids market in the coming years. Personal care products include items such as skincare, haircare, oral care, and hygiene products used for grooming and maintaining cleanliness and appearance. The use of personal care products is rising due to higher disposable incomes, growing awareness of health and hygiene, evolving demographics, social media influence, and the expanding self-care trend. Rhamnolipids enhance personal care products by offering effective cleansing, moisturizing, and mild performance while providing eco-friendly and efficiency-improving advantages. For instance, in September 2024, according to the Bureau of Labor Statistics (BLS), a U.S.-based federal agency, U.S. household spending on personal care products and services increased by 9.7% in 2023 compared to 2022. Therefore, the rising demand for personal care products is fueling the growth of the rhamnolipids market.

Major companies in the rhamnolipids market are prioritizing advanced innovations, such as large-scale fermentation production capacity, to strengthen their competitive position. Industrial-scale rhamnolipid production involves manufacturing biosurfactants in high volumes through fermentation processes using renewable feedstocks, enabling broader use in cleaning, personal care, agriculture, and industrial sectors. For instance, in March 2025, AGAE Technologies, a US-based biosurfactant manufacturer, established a large-scale production plant in Asia capable of generating more than 1,000 metric tons of rhamnolipids annually. The facility incorporates upgraded fermentation and foam-control systems, offers both granular and liquid rhamnolipid forms, and supports further capacity expansion as demand increases. These advancements reduce unit costs and enhance supply stability, promoting wider adoption of rhamnolipids as sustainable alternatives. The increased production capability improves global supply chain strength, though companies must maintain consistent product quality and meet regulatory standards for large-scale distribution.

In January 2023, Sasol Limited, a South Africa-based supplier of chemicals, surfactants, and specialty solutions, broadened its strategic partnership with Holiferm Limited to develop and commercialize rhamnolipid-based sustainable surfactants. Through this extended collaboration, Sasol aimed to expand its portfolio of environmentally friendly surfactants, accelerate the market uptake of biodegradable biosurfactants, and integrate Holiferm's rhamnolipid fermentation technology into its global product lines. Holiferm Limited is a US-based producer of microbial rhamnolipids and other biosurfactants for personal care, home care, and industrial cleaning applications.

Major companies operating in the rhamnolipids market are Jeneil Biotech Inc, AGAE Technologies LLC, Evonik Industries AG, Biotensidon GmbH, Shaanxi Deguan Biotechnology Co. Ltd, Zhejiang Silver-Elephant Bio-engineering Co. Ltd, Zhejiang Shengda Zijin Biotech Co. Ltd, TeeGene Biotech, Rhamnolipid Companies, Inc, Paradigm Biomedical Inc, Locus Bio-Energy Solutions, Teego Technologies, Altinbio Scientific Private Limited, NatSurFact Laboratories, Aumgene Biosciences Pvt. Ltd, Jiangsu WanQi Biotechnology Co. Ltd, Rhamnolipid, Inc, Shandong Aikang Biotechnology, Xi'an Rege Biotechnology, Zilorium Biologics, Locus Performance Ingredients

Asia-Pacific was the largest region in the rhamnolipids market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the rhamnolipids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the rhamnolipids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The rhamnolipids market consists of sales of complex rhamnolipids, uncommon rhamnolipids, household cleaners, and personal care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rhamnolipids Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses rhamnolipids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rhamnolipids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rhamnolipids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Mono-Rhamnolipids; Di-Rhamnolipids
• 2) By Form: Liquid; Powder
• 3) By Application: Surfactants; Cosmetics; Agriculture; Other Applications
• Subsegments:
• 1) By Mono-Rhamnolipids: Rhamnolipid C10 (Mono-Rhamnolipid With 10-Carbon Chain); Rhamnolipid C12 (Mono-Rhamnolipid With 12-Carbon Chain); Rhamnolipid C14 (Mono-Rhamnolipid With 14-Carbon Chain); Other Mono-Rhamnolipids (Based On Different Fatty Acid Chains)
• 2) By Di-Rhamnolipids: Di-Rhamnolipid C10 (Di-Rhamnolipid With 10-Carbon Chain); Di-Rhamnolipid C12 (Di-Rhamnolipid With 12-Carbon Chain); Di-Rhamnolipid C14 (Di-Rhamnolipid With 14-Carbon Chain); Other Di-Rhamnolipids (Based On Different Fatty Acid Chains)
• Companies Mentioned: Jeneil Biotech Inc; AGAE Technologies LLC; Evonik Industries AG; Biotensidon GmbH; Shaanxi Deguan Biotechnology Co. Ltd; Zhejiang Silver-Elephant Bio-engineering Co. Ltd; Zhejiang Shengda Zijin Biotech Co. Ltd; TeeGene Biotech; Rhamnolipid Companies, Inc; Paradigm Biomedical Inc; Locus Bio-Energy Solutions; Teego Technologies; Altinbio Scientific Private Limited; NatSurFact Laboratories; Aumgene Biosciences Pvt. Ltd; Jiangsu WanQi Biotechnology Co. Ltd; Rhamnolipid, Inc; Shandong Aikang Biotechnology; Xi'an Rege Biotechnology; Zilorium Biologics; Locus Performance Ingredients
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.